1. Home
  2. OPRA vs STOK Comparison

OPRA vs STOK Comparison

Compare OPRA & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Opera Limited

OPRA

Opera Limited

HOLD

Current Price

$17.36

Market Cap

1.7B

Sector

Technology

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$24.97

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPRA
STOK
Founded
1996
2014
Country
Norway
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
OPRA
STOK
Price
$17.36
$24.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
14
Target Price
$26.29
★ $46.46
AVG Volume (30 Days)
266.4K
★ 782.2K
Earning Date
11-17-2026
10-29-2026
Dividend Yield
★ 4.51%
N/A
EPS Growth
N/A
★ 92.73
EPS
★ N/A
N/A
Revenue
N/A
★ $184,420,000.00
Revenue This Year
$20.36
N/A
Revenue Next Year
$15.27
$39.98
P/E Ratio
$13.62
★ N/A
Revenue Growth
N/A
★ 404.50
52 Week Low
$11.71
$20.32
52 Week High
$20.78
$40.22

Technical Indicators

Market Signals
Indicator
OPRA
STOK
Relative Strength Index (RSI) 44.03 45.36
Support Level $17.02 $24.21
Resistance Level $18.02 $33.61
Average True Range (ATR) 0.54 1.33
MACD 0.05 0.35
Stochastic Oscillator 44.13 56.19

Price Performance

Historical Comparison
OPRA
STOK

About OPRA Opera Limited

Opera Ltd is a consumer internet software company providing a diversified portfolio of high-performance web browsers and adjacent digital services to engaged user base The company has transitioned from browser developer to multi-faceted platform offering a products and services that include PC and mobile browsers, its Opera Gaming portals and development tools, Opera News content platforms, Opera Ads platform, as well as a number of AI and web3 products and services, such as MiniPay and Opera AI, to a user base.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: